ephedrine has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Covey, TR; Liu, C; Olah, TV; Shou, WZ; Wagner, A; Weller, HBN; Zhang, J | 1 |
1 review(s) available for ephedrine and gemcitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ephedrine and gemcitabine
| Article | Year |
|---|---|
Ultrahigh-Throughput and Chromatography-Free Bioanalysis of Polar Analytes with Acoustic Ejection Mass Spectrometry.
Topics: Acoustics; Deoxycytidine; Ephedrine; Ethambutol; Gemcitabine; HEK293 Cells; High-Throughput Screening Assays; Humans; Isoniazid; Mass Spectrometry | 2020 |